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Supporting Table 1. Age specific incidence rates per 100,000 per year for leg fractures: femur (not neck),  neck of femur,  lower leg, and ankle in post-menopausal women 
 
  Femur (not neck) Neck of femur Lower leg Ankle 
 Person Years Incident  
cases 
Incidence rate 














Incidence rate per 
100,000  
(95% CI) 
Age (years)          
50-54  469,406 20 5.4 (2.4-8.5) 86 16.2 (11.9-20.6) 79 19.8 (14.1-25.6) 250 50.8 (42.9-58.7) 
55-59  3,376,760 148 4.3 (3.6-5.0) 873 25.3 (23.6-26.9) 669 19.6 (18.1-21.1) 2250 65.6 (62.9-68.4) 
60-64  4,178,337 290 7.0 (6.2-7.8) 2222 53.4 (51.1-55.6) 981 23.5 (22.0-24.9) 3401 81.5 (78.7-84.2) 
65-69  2,824,762 313 11.5 (10.2-12.8) 2662 98.2 (94.4-102.0) 838 29.7 (27.7-31.8) 2540 89.8 (86.3-93.4) 
70-74  1,273,714 292 25.2 (22.1-28.2) 2665  227.4 (218.3-236.5) 501 40.3 (36.6-44.0) 1357 109.6 (103.5-115.8) 




Supporting Table 2. Age specific incidence rates per 100,000 per year for arm fractures: forearm (not wrist), wrist, and humerus in post-menopausal women 
 
  Forearm (not wrist) Wrist  Humerus 
 Person Years Incident  
cases 
Incidence rate per 
100,000 (95% CI) 
Incident  
cases 
Incidence rate per 
100,000 (95% CI) 
Incident  
cases 
Incidence rate per 
100,000 (95% CI) 
Age (years)        
50-54  469,406 62 12.3 (8.2-16.3) 272 50.7 (43.4-57.9) 60 12.9 (8.7-17.1) 
55-59  3,376,760 544 15.9 (14.6-17.3) 2761 80.2 (77.2-83.2) 572 16.4 (15.1-17.8) 
60-64  4,178,337 893 21.4 (20.0-22.8) 4938 118.3 (115.0-121.6) 1334 32.0 (30.3-33.7) 
65-69  2,824,762 794 28.8 (26.7-30.8) 4487 161.9 (157.1-166.7) 1387 50.1 (47.5-52.8) 
70-74  1,273,714 471 37.9 (34.3-41.5) 2674 217.2 (208.5-225.8) 1158 95.6 (89.7-101.4) 
75-79 231,944 134 55.6 (44.2-67.0) 627 285.6 (256.4-314.8) 337 153.8 (132.9-174.7) 
 
  
Supporting Table 3. Adjusteda relative risks of femur (not neck),  neck of femur,  lower leg, and ankle fractures in women, cross-classified by both BMI and 
strenuous physical activity, and BMI and any activity 
 
 Strenuous Physical Activity Any activity 
BMI (kg/m2) Rarely/never active 
At most once per 
week 
RR (gsCI) 
More than once 
per week  
RR (gsCI) 
P for 
interaction Rarely/never active 
At most once per 
week 
RR (gsCI) 
2-3 times per 
week  
RR (gsCI) 
More than 3 times 




Femur (not neck)          
<25.0 1.00 (0.88-1.13)c 0.67 (0.56-0.81) 0.61 (0.49-0.76) .13b 1.00 (0.82-1.22)c 0.58 (0.45-0.75) 0.56 (0.44-0.71) 0.81 (0.69-0.96) .52c 
25.0-29.9 0.94 (0.83-1.08) 0.61 (0.49-0.76) 0.72 (0.56-0.93)  0.85 (0.69-1.03) 0.59 (0.46-0.75) 0.67 (0.53-0.85) 0.81 (0.67-0.98)  
30.0+ 1.18 (1.01-1.38) 1.16 (0.90-1.50) 0.80 (0.54-1.18)  1.16 (0.95-1.42) 0.93 (0.72-1.21) 0.79 (0.56-1.10) 0.91 (0.68-1.21)  
          
Neck of femur           
<25.0 1.00 (0.96-1.04)c 0.75 (0.71-0.79) 0.67 (0.63-0.72) .04b 1.00 (0.94-1.06)c 0.81 (0.76-0.87) 0.73 (0.68-0.78) 0.84 (0.80-0.88) .05c 
25.0-29.9 0.61 (0.58-0.64) 0.49 (0.46-0.53) 0.46 (0.42-0.50)  0.58 (0.53-0.62) 0.49 (0.45-0.53) 0.51 (0.47-0.55) 0.54 (0.50-0.58)  
30.0+ 0.47 (0.43-0.50) 0.43 (0.38-0.48) 0.36 (0.30-0.43)  0.46 (0.41-0.50) 0.39 (0.34-0.44) 0.39 (0.34-0.46) 0.47 (0.42-0.53)  
          
Lower Leg          
<25.0 1.00 (0.92-1.09)c 0.95 (0.86-1.05) 0.99 (0.89-1.11) .52b 1.00 (0.87-1.15)c 0.88 (0.77-1.01) 0.80 (0.71-0.91) 1.01 (0.92-1.11) .52c 
25.0-29.9 1.07 (0.98-1.16) 1.12 (1.01-1.24) 1.07 (0.93-1.22)  1.09 (0.96-1.24) 1.03 (0.91-1.17) 0.89 (0.78-1.02) 1.09 (0.98-1.22)  
30.0+ 1.17 (1.05-1.30) 1.11 (0.94-1.31) 1.40 (1.16-1.70)  1.20 (1.04-1.38) 1.10 (0.93-1.29) 0.95 (0.78-1.16) 1.23 (1.04-1.46)  
          
Ankle          
<25.0 1.00 (0.95-1.05)c 0.97 (0.91-1.03) 1.03 (0.96-1.10) .05b 1.00 (0.92-1.09)c 0.88 (0.81-0.95) 0.91 (0.85-0.98) 0.96 (0.92-1.03) .58c 
25.0-29.9 1.40 (1.34-1.47) 1.48 (1.40-1.56) 1.49 (1.39-1.60)  1.35 (1.25-1.45) 1.31 (1.22-1.40) 1.30 (1.21-1.39) 1.47 (1.39-1.56)  
30.0+ 1.63 (1.53-1.72) 1.80 (1.67-1.95) 1.53 (1.36-1.71)  1.52 (1.40-1.65) 1.54 (1.41-1.67) 1.49 (1.35-1.65) 1.61 (1.47-1.76)  
BMI indicates body mass index; gsCI, group-specific confidence interval for RR; and RR, relative risk. 
a Adjusted for study region, age, socio-economic status, smoking, alcohol consumption, use of hormone therapy, height, heart disease/thrombosis, diabetes 
mellitus, thyroid disease, rheumatoid arthritis/osteoarthritis, and exercise 
b Likelihood ratio test for interaction between categories of BMI and strenuous activity 




Supporting Table 4. Adjusteda relative risks of forearm (not wrist), wrist, and humerus fractures in women, cross-classified by both BMI and strenuous physical activity, 
and BMI and any activity 
 
 Strenuous Physical Activity Any Activity 
BMI (kg/m2) Rarely/never active 
At most once per 
week 
RR (gsCI) 
More than once 
per week  
RR (gsCI) 
P for 
interaction Rarely/never active 
At most once per 
week 
RR (gsCI) 
2-3 times per 
week  
RR (gsCI) 
More than 3 times 




Forearm (not wrist)          
<25.0 1.00 (0.92-1.08) 0.93 (0.84-1.02) 1.02 (0.92-1.13) .54b 1.00 (0.87-1.15) 1.09 (0.96-1.23) 0.86 (0.76-0.97) 1.10 (1.00-1.20) .03c 
25.0-29.9 0.83 (0.75-0.91) 0.78 (0.69-0.88) 0.80 (0.63-0.93)  0.88 (0.76-1.02) 0.85 (0.74-0.98) 0.90 (0.79-1.03) 0.82 (0.72-0.93)  
30.0+ 0.89 (0.79-1.00) 0.72 (0.59-0.87) 0.72 (0.55-0.93)  0.92 (0.78-1.09) 0.77 (0.63-0.93) 0.85 (0.68-1.05) 0.75 (0.60-0.93)  
          
Wrist          
<25.0 1.00 (0.97-1.03) 0.99 (0.95-1.03) 1.03 (0.99-1.08) .83b 1.00 (0.94-1.06) 0.90 (0.86-0.95) 0.92 (0.88-0.96) 0.95 (0.92-0.99) .88c 
25.0-29.9 0.76 (0.75-0.81) 0.79 (0.75-0.83) 0.80 (0.75-0.85)  0.76 (0.71-0.81) 0.73 (0.69-0.77) 0.73 (0.69-0.78) 0.74 (0.70-0.78)  
30.0+ 0.61 (0.58-0.65) 0.61 (0.56-0.67) 0.59 (0.53-0.67)  0.59 (0.54-0.64) 0.56 (0.51-0.62) 0.55 (0.49-0.61) 0.60 (0.54-0.66)  
          
Humerus          
<25.0 1.00 (0.94-1.07) 0.92 (0.85-1.00) 0.85 (0.77-0.93) .84b 1.00 (0.90-1.11) 0.95 (0.85-1.05) 0.92 (0.83-1.01) 0.96 (0.89-1.04) .76c 
25.0-29.9 1.03 (0.97-1.10) 0.90 (0.82-0.99) 0.84 (0.74-0.94)  0.97 (0.87-1.08) 0.92 (0.83-1.02) 0.90 (0.81-1.01) 1.04 (0.95-1.14)  
30.0+ 1.17 (1.08-1.27) 1.10 (0.96-1.25) 0.90 (0.75-1.09)  1.08 (0.96-1.22) 1.09 (0.95-1.24) 1.01 (0.86-1.18) 1.23 (1.08-1.41)  
BMI indicates body mass index; gsCI, group-specific confidence interval for RR; and RR, relative risk. 
a Adjusted for study region, age, socio-economic status, smoking, alcohol consumption, use of hormone therapy, height, heart disease/thrombosis, diabetes 
mellitus, thyroid disease, rheumatoid arthritis/osteoarthritis, and exercise 
b Likelihood ratio test for interaction between categories of BMI and strenuous activity 
c Likelihood ratio test for interaction between categories of BMI and any activity. 
  
Supporting Table 5. Sensitivity analyses of hormone therapy for relative risk of femur (not neck),  neck of femur,  lower leg, and ankle fractures in post-
menopausal women according to strenuous physical activity, and any activity a 
 
 Femur (not neck) Neck of femur Lower leg Ankle 
 Current users of 
hormone 
therapy 




RR (95% gsCI) 
Current users of 
hormone 
therapy 




RR (95% gsCI) 
Current users of 
hormone 
therapy 




RR (95% gsCI) 
Current users of 
hormone 
therapy 




RR (95% gsCI) 
BMI (kg/m2)         
<20.0 1.44 (0.88-2,37) 1.87 (1.41-2.52) 1.80 (1.57-2.07) 1.96 (1.81-2.21) 0.88 (0.60-1.27) 1.28 (1.04-1.56) 0.64 (0.49-0.82) 0.66 (0.56-0.79) 
20.0-24.9 1.00 (0.83-1.20) 1.00 (0.88-1.13) 1.00 (0.94-1.06) 1.00 (0.97-1.04) 1.00 (0.90-1.11) 1.00 (0.93-1.07) 1.00 (0.94-1.06) 1.00 (0.96-1.04) 
25.0-29.9 1.01 (0.83-1.23) 1.06 (0.94-1.19) 0.69 (0.64-0.74) 0.67 (0.64-0.70) 1.11 (0.99-1.24) 1.11 (1.04-1.19) 1.48 (1.40-1.56) 1.37 (1.32-1.42) 
30.0-34.9 1.07 (0.77-1.48) 1.30 (1.10-1.54) 0.59 (0.51-0.68) 0.52 (0.49-0.56) 1.37 (1.14-1.63) 1.19 (1.07-1.32_ 1.95 (1.79-2.13) 1.54 (1.45-1.63) 
35+ 1.43 (0.88-2.33) 1.87 (1.51-2.33) 0.65 (0.51-0.83) 0.48 (0.42-0.54) 1.61 (1.21-2.15) 1.12 (0.94-1.32) 1.70 (1.44-2.01) 1.45 (1.32-1.59) 
Pheterogeneity  .51 <.001 <.001 <.001 <.05 <.05 <.001 <.001 
Pinteraction .75 .14 <.05 <.001 
         
Strenuous Exercise          
Rarely/never (inactive) 1.00 (0.82-1.22) 1.00 (0.83-1.16) 1.00 (0.93-1.07) 1.00 (0.96-1.04) 1.00 (0.88-1.13) 1.00 (0.93-1.08) 1.00 (0.94-1.07) 1.00 (0.96-1.04) 
At most once per week 0.83 (0.66-1.04) 0.66 (0.57-0.77) 0.81 (0.75-0.87) 0.77 (0.74-0.81) 1.09 (0.97-1.23) 0.95 (0.88-1.03) 0.94 (0.88-1.01) 1.06 (1.02-1.11) 
More than once per week 0.76 (0.57-1.02) 0.67 (0.56-0.80) 0.69 (0.62-0.76) 0.70 (0.66-0.75) 1.26 (1.09-1.47) 0.95 (0.86-1.05) 1.02 (0.94-1.11) 1.04 (0.98-1.10) 
Pheterogeneity  .25 <.001 <.001 <.001 .06 .57 .42 .12 
Pinteraction .51  .56  .34 .08 .003  
         
Any Activity         
Rarely/never (inactive) 1.00 (0.76-1.32) 1.00 (0.86-1.16) 1.00 (0.90-1.11) 1.00 (0.95-1.06) 1.00 (0.83-1.20) 1.00 (0.90-1.11) 1.00 (0.91-1.10) 1.00 (0.94-1.07) 
At most once per week 0.70 (0.53-0.91) 0.67 (0.56-0.80) 0.85 (0.78-0.94) 0.84 (0.79-0.89) 0.92 (0.791.06) 0.90 (0.82-0.99) 1.01 (0.93-1.09) 0.93 (0.88-0.98) 
2-3 times per week 0.48 (0.34-0.67) 0.70 (0.59-0.83) 0.93 (0.85-1.02) 0.75 (0.71-0.809) 0.71 (0.61-0.84) 0.84 (0.76-0.93) 0.96 (0.88-1.04) 0.95 (0.90-1.00) 
More than 3 times per week 0.90 (0.72-1.12) 0.83 (0.72-0.95) 1.03 (0.95-1.11) 0.83 (0.79-0.87) 0.86 (0.75-0.98) 1.05 (0.97-1.14) 1.15 (1.07-1. 23) 1.00 (0.95-1.04) 
Pheterogeneity  <.05 <.05 <.05 <.001 <.05 <.001 <.05 .14 
Pinteraction .22  <.05  .62  .19  
BMI indicates body mass index; gsCI, group-specific confidence interval for RR; and RR, relative risk. 
a Adjusted for study region, age, socio-economic status, smoking, alcohol consumption,  height, heart disease/thrombosis, diabetes mellitus, thyroid disease, 
rheumatoid arthritis/osteoarthritis, and BMI (for adjustment of strenuous activity and any activity), strenuous activity (for adjustment of BMI and any activity), or 
any activity (for adjustment of BMI and strenuous activity). 
  
 
Supporting Table 6. Sensitivity analyses of hormone therapy for relative risk of forearm (not wrist), wrist, and humerus fractures in post-menopausal women 
according to BMI, strenuous physical activity, and any activity a 
 Forearm (not wrist) Wrist Humerus 
 Current users of 
hormone therapy 




RR (95% gsCI) 
Current users of 
hormone therapy 
RR (95% gsCI) 
Never/past hormone 
therapy use 
RR (95% gsCI) 
Current users of 
hormone therapy 
RR (95% gsCI) 
Never/past hormone 
therapy use 
RR (95% gsCI) 
BMI (kg/m2)       
<20.0 1.41 (1.03-1.91) 1.44 (1.19-1.73) 1.05 (0.90-1.22) 1.00 (1.16-1.37) 1.25 (0.96-1.63) 1.19 (1.00-1.40) 
20.0-24.9 1.00 (0.90-1.12) 1.00 (0.94-1.07) 1.00 (0.95-1.05) 1.00 (0.97-1.03) 1.00 (0.91-1.09) 1.00 (0.95-1.06) 
25.0-29.9 0.99 (0.87-1.11) 0.79 (0.74-0.85) 0.80 (0.75-0.84) 0.80 (0.77-0.82) 1.10 (1.00-1.21) 1.00 (0.95-1.06) 
30.0-34.9 0.91 (0.72-1.15) 0.84 (0.75-0.95) 0.67 (0.60-0.75) 0.63 (0.60-0.67) 1.25 (1.07-1.47) 1.11 (1.02-1.21) 
35+ 0.73 (0.46-1.15) 0.82 (0.68-0.99) 0.65 (0.53-0.80) 0.54 (0.49-0.60) 1.52 (1.17-1.98) 1.25 (1.10-1.43) 
Pheterogeneity  .15 <.001 <.001 <.001 <.05 <.001 
Pinteraction .26  .19  .69  
       
Strenuous Exercise        
Rarely/never (inactive) 1.00 (0.87-1.15) 1.00 (0.93-1.08) 1.00 (0.94-1.06) 1.00 (0.97-1.03) 1.00 (0.90-1.11) 1.00 (0.95-1.06) 
At most once per week 1.15 (1.02-1.30) 0.85 (0.78-0.92) 1.03 (0.97-1.09) 1.00 (0.96-1.03) 0.99 (0.90-1.10) 0.89 (0.84-0.95) 
More than once per week 1.06 (0.90-1.24) 0.95 (0.86-1.05) 1.05 (0.98-1.13) 1.02 (0.98-1.07) 0.82 (0.71-0.94) 0.83 (0.76-0.90) 
Pheterogeneity  .33 <.05 .60 .58 <.05 <.001 
Pinteraction <.05  .81  .52  
       
Any Activity       
Rarely/never (inactive) 1.00 (0.81-1.24) 1.00 (0.89-1.12) 1.00 (0.91-1.09) 1.00 (0.95-1.05) 1.00 (0.86-1.16) 1.00 (0.92-1.09) 
At most once per week 0.92 (0.78-1.09) 1.01 (0.92-1.11) 0.85 (0.79-0.92) 0.95 (0.91-0.99) 0.83 (0.73-0.95) 0.99 (0.92-1.07) 
2-3 times per week 0.99 (0.84-1.16) 0.85 (0.77-0.94) 0.83 (0.77-0.89) 0.97 (0.93-1.01) 0.89 (0.78-1.01) 0.93 (0.86-1,00) 
More than 3 times per week 1.06 (0.93-1.22) 0.94 (0.87-1.03) 0.93 (0.87-0.99) 0.97 (0.93-1.00) 0.95 (0.85-1.07) 1.06 (0.99-1.13) 
Pheterogeneity  .63 .09 <.001 .53 .23 .07 
Pinteraction .11  <.05  .44  
BMI indicates body mass index; gsCI, group-specific confidence interval for RR; and RR, relative risk. 
a Adjusted for study region, age, socio-economic status, smoking, alcohol consumption,  height, heart disease/thrombosis, diabetes mellitus, thyroid disease, 
rheumatoid arthritis/osteoarthritis, and BMI (for adjustment of strenuous activity and any activity), strenuous activity (for adjustment of BMI and any activity), or 
any activity (for adjustment of BMI and strenuous activity). 
  
Supporting Table 7. Sensitivity analyses of adjusteda relative risks of femur (not neck),  neck of femur,  lower leg, and ankle fractures in post-menopausal women 
according to BMI,  stratified by age-bands. 
 



























             
50-64.9 years             
<20.0 40 143 29 1.83 (1.27-2.65) 40 143 336 2.11 (1.89-2.35) 40 142 73 1.21 (0.96-1.52) 40 142 104 0.61 (0.50-0.74) 
20.0-24.9 476 464 168 1.00 (0.85-1.17) 476 468 1646 1.00 (0.95-1.05) 476 471 684 1.00 (0.92-1.08) 476 466 2004 1.00 (0.96-1.05) 
25.0-29.9 398 181 145 1.01 (0.86-1.18) 398 184 857 0.62 (0.58-0.67) 398 182 626 1.15 (1.07-1.25) 398 188 2373 1.51 (1.45-1.57) 
30.0-34.9 141 028 67 1.19 (0.93-1.51) 141 028 231 0.43 (0.38-9.50) 141 028 240 1.23 (1.08-1.40) 141 033 1024 1.87 (1.76-1.99) 
35+ 57 956 46 1.71 (1.26-2.31) 57 956 101 0.40 (0.33-0.49) 57 958 99 1.16 (0.94-1.41) 57 956 376 1.65 (1.49-1.83) 
Pheterogeneity   <.05   <.001   <.05   <.001 
             
65-69.9             
<20.0 26 106 16 1.77 (1.08-2.90) 26 122 240 2.05 (1.81-2.34) 26 107 26 0.96 (0.65-1.41) 26 106 46 0.65 (0.48-0.86) 
20.0-24.9 322 792 102 1.00 (0.82-1.23) 322 850 1253 1.00 (0.94-1.06) 322 797 311 1.00 (0.89-1.12) 322 799 875 1.00 (0.93-1.07) 
25.0-29.9 283 311 114 1.15 (0.96-1.38) 283 340 829 0.71 (0.67-0.76) 283 319 315 1.12 (1.00-1.24) 283 328 1055 1.35 (1.27-1.43) 
30.0-34.9 98 929 53 1.36 (1.04-1.80) 98 941 232 0.53 (0.46-0.60) 98 932 134 1.30 (1.09-1.55) 98 934 416 1.50 (1.36-1.66) 
35+ 37 785 26 1.58 (1.06-2.35) 37 789 90 0.50 (0.40-0.61) 37 784 50 1.21 (0.91-1.61) 37 784 144 1.36 (1.15-1.61) 
Pheterogeneity   .10    <.001   .15   <.001 
             
70+             
<20.0 13 102 20  1.60 (1.03-2.49) 13 114 272 1.53 (1.36-1.73) 13 100 24 1.16 (0.78-1.74) 13 099 42 0.83 (0.61-1.13) 
20.0-24.9 163 770 140 1.00 (0.84-1.19) 163 836 1915 1.00 (0.95-1.05) 163 762 233 1.00 (0.87-1.15) 163 786 599 1.00 (0.92-1.09) 
25.0-29.9 152 767  135 1.01 (0.85-1.19) 152 824 1271 0.71 (0.67-0.74) 152 766 234 1.04 (0.92-1.18) 152 778 677 1.22 (1.14-1.32) 
30.0-34.9 53 156 60 1.22 (0.94-1.57) 53 180 418 0.65 (0.59-0.72) 53 160 98 1.20 (0.98-1.47) 53 162 235 1.25 (1.09-1.42) 
35+ 19 017 36 2.02 (1.43-2.84) 19 020 136 0.61 (0.52-0.73) 19 019 42 1.40 (1.02-1.92) 19 019 86 1.36 (1.09-1.64) 
Pheterogeneity   <.05   <.001   .30   <.001 
BMI indicates body mass index; gsCI, group-specific confidence interval for RR; and RR, relative risk. 
a Adjusted for study region, age, socio-economic status, smoking, alcohol consumption,  height, heart disease/thrombosis, diabetes mellitus, thyroid disease, 
rheumatoid arthritis/osteoarthritis, strenuous activity and any activity. 
 
  
Supporting Table 8. Sensitivity analyses of adjusteda relative risks of forearm (not wrist), wrist and humerus fracture in post-
menopausal women according to BMI, stratified by age-bands. 
 
 Forearm (not wrist) Wrist Humerus 
 


















RR (95% gsCI) 
 
50-64.9 years 
         
<20.0 40 142 83 1.40 (1.13-1.75) 40 144 363 1.11 (1.00-1.23) 40 146 93 1.30 (1.06-1.59) 
20.0-24.9 476 466 681 1.00 (0.92-1.08) 476 468 3955 1.00 (0.97-1.03) 476 467 784 1.00 (0.93-1.08) 
25.0-29.9 398 181 473 0.88 (0.81-0.96) 398 192 2612 0.82 (0.78-0.85) 398 184 674 1.07 (0.99-1.15) 
30.0-34.9 141 027 171 0.90 (0.77-1.04) 141 031 735 0.65 (0.60-0.70) 141 028 272 1.19 (1.05-1.34) 
35+ 55 957 80 0.98 (0.78-1.23) 57 956 273 0.57 (0.51-0.65) 57 957 138 1.36 (1.14-1.62) 
Pheterogeneity   <.05   <.001   <.05 
          
65-69.9          
<20.0 26 105 45 1.49 (1.11-2.01) 26 119 214 1.24 (1.08-1.41) 26 112 60 1.29 (1.00-1.67) 
20.0-24.9 322 811 360 1.00 (0.90-1.11) 322 844 2135 1.00 (0.96-1.05) 322 815 535 1.00 (0.91-1.09) 
25.0-29.9 283 314 245 0.75 (0.66-0.85)  283 362 1529 0.79 (0.75-0.83) 283 341 497 1.02 (0.94-1.12) 
30.0-34.9 98 933 116 0.99 (0.82-1.19) 98 936 446 0.65 (0.59-0.71) 98 933 195 1.11 (0.97-1.29) 
35+ 37 786 25 0.56 (0.37-0.83) 37 788 137 0.53 (0.45-0.63) 37 787 96 1.41 (1.15-1.74)  
Pheterogeneity   <.001   <.001   <.05 
          
70+          
<20.0 13 099 33 1.42 (1.00-2.00) 13 109 182 1.34 (1.15-1.55) 13 104 54 0.99 (0.76-1.30) 
20.0-24.9 163 764 280 1.00 (0.88-1.13) 163 816 1617 1.00 (0.95-1.05) 163 789 614 1.00 (0.92-1.09) 
25.0-29.9 152 765 234 0.88 (0.77-1.00) 152 797 1184 0.77 (0.73-0.82) 152 788 586 1.00 (0.93-1.09) 
30.0-34.9 53 154 59 0.63 (0.48-0.81) 53 162 327 0.62 (0.56-0.69) 53 164 228 1.09 (0.95-1.25) 
35+ 19 018 27 0.82 (0.56-1.21) 19 022 100 0.56 (0.46-0.68) 19 021 85 1.16 (0.93-1.44) 
Pheterogeneity   <.05   <.001   .67  
BMI indicates body mass index; gsCI, group-specific confidence interval for RR; and RR, relative risk. 
a Adjusted for study region, age, socio-economic status, smoking, alcohol consumption,  height, heart disease/thrombosis, diabetes mellitus, thyroid disease, 




Supporting Table 9. Sensitivity analyses of adjusteda relative risks femur (not neck), neck of femur, lower leg, and ankle fracture in post-menopausal women according to 
strenuous activity, stratified by age-bands.  
 


























RR (95% gsCI) 
             
50-64.9             
Rarely/never (inactive) 529914 276 1.00 (0.85-1.18) 529915 1826 1.00 (0.94-1.06) 529918 821 1.00 (0.91-1.09) 529920 2771 1.00 (0.95-1.05) 
At most once per week  345709 104 0.71 (0.59-0.87) 345711 815 0.73 (0.68-0.78) 345710 519 0.99 (0.91-1.08) 345713 1816 1.01 (0.96-1.05) 
More than once per week 238149 75 0.69 (0.54-0.87) 238153 530 0.64 (0.59-0.70) 238153 382 1.02 (0.92-1.14) 238152 1294 1.04 (0.98-1.10) 
Pheterogeneity   <.05   <.001   .91   .64 
             
65-69.9             
Rarely/never (inactive) 374225 199 1.00 (0.82-1.21) 374293 1567 1.00 (0.94-1.07) 374228 444 1.00 (0.89-1.13) 374243 1240 1.00 (0.93-1.07) 
At most once per week  232448 71 0.83 (0.65-1.04) 232477 642 0.77 (0.71-0.83) 232460 220 0.95 (0.83-1.09) 232457 775 1.10 (1.02-1.18) 
More than once per week 162250 41 0.66 (0.48-0.90) 162272 435 0.70 (0.64-0.78) 162251 172 1.02 (0.87-1.20) 162251 521 1.06 (0.96-1.16) 
Pheterogeneity   .15   <.001   .77   .18 
             
70+             
Rarely/never (inactive) 204344 258 1.00 (0.85-1.17) 204444 2444 1.00 (0.95-1.05) 204339 353 1.00 (0.87-1.14) 204356 865 1.00 (0.92-1.09) 
At most once per week  114982 71 0.63 (0.50-0.80) 115021 927 0.83 (0.78-0.89) 114983 162 1.03 (0.88-1.20) 114995 456 1.04 (0.95-1.14) 
More than once per week 82846 62 0.70 (0.54-0.91) 82509 642 0.75 (0.69-0.81) 82485 116 1.03 (0.85-1.25) 82493 318 0.98 (0.87-1.10) 
Pheterogeneity   <.05   <.001   .96   .72 
gsCI indicates group-specific confidence interval for RR; and RR indicates relative risk. 
a Adjusted for study region, age, socio-economic status, smoking, alcohol consumption,  height, heart disease/thrombosis, diabetes mellitus, thyroid disease, 
rheumatoid arthritis/osteoarthritis, BMI and any activity. 
 
  
Supporting Table 10. Sensitivity analyses of adjusteda relative risks forearm (not wrist), wrist and humerus fracture in post-menopausal 
women according to strenuous activity, stratified by age-bands.   
 




















RR (95% gsCI) 
          
50-64.9          
Rarely/never (inactive) 529911 700 1.00 (0.91-1.10) 529914 3535 1.00 (0.96-1.04) 529918 1027 1.00 (0.92-1.08) 
At most once per week  345709 446 0.91 (0.83-1.00) 345715 2506 1.03 (0.99-1.07) 345713 560 0.87 (0.80-0.95) 
More than once per week 238153 342 1.03 (0.91-1.16) 238162 1897 1.11 (1.06-1.17) 238151 374 0.82 (0.74-0.92) 
Pheterogeneity   .22   <.05   <.05 
          
65-69.9          
Rarely/never (inactive) 374237 426 1.00 (0.89-1.13) 374292 2201 1.00 (0.94-1.05) 374263 765 1.00 (0.91-1.10) 
At most once per week  232459 221 0.87 (0.76-0.99) 232484 1325 0.98 (0.93-1.04) 232464 374 0.94 (0.85-1.04) 
More than once per week 162253 144 0.76 (0.64-0.90) 162273 935 0.96 (0.89-1.02) 162261 244 0.83 (0.73-0.95) 
Pheterogeneity   <.05   .60   .08 
          
70+          
Rarely/never (inactive) 204328 328 1.00 (0.88-1.14) 204391 1805 1.00 (0.94-1.06) 204370 896 1.00 (0.92-1.09) 
At most once per week  114983 162 0.97 (0.83-1.13) 115011 926 0.98 (0.92-1.05) 115004 408 0.94 (0.85-1.03) 
More than once per week 82849 143 1.15 (0.92-1.43) 82504 679 0.94 (0.87-1.02) 82492 263 0.81 (0.72-0.92) 
Pheterogeneity   .32   .45   <.05 
gsCI indicates group-specific confidence interval for RR; and RR indicates relative risk. 
a Adjusted for study region, age, socio-economic status, smoking, alcohol consumption,  height, heart disease/thrombosis, diabetes mellitus, thyroid disease, 
rheumatoid arthritis/osteoarthritis, BMI and any activity. 
  
Supporting Table11. Sensitivity analyses of adjusteda relative risks femur (not neck), neck of femur, lower leg, and ankle fracture in post-menopausal women according to any 
activity, stratified by age-bands.  
 


























RR (95% gsCI) 
             
50-64.9             
Rarely/never 213464 130 1.00 (0.83-1.20) 213464 790 1.00 (0.93-1.08) 213465 351 1.00 (0.90-1.11) 213465 1166 1.00 (0.94-1.06) 
At most once per week 243701 83 0.63 (0.51-0.78) 243702 633 0.74 (0.68-0.80) 243702 356 0.90 (0.81-1.00) 243703 1275 0.96 (0.91-1.01) 
2-3 times week 238931 60 0.49 (0.38-0.64) 238933 522 0.61 (0.56-0.67) 238932 330 0.89 (0.80-0.99) 238933 1187 0.97 (0.91-1.03) 
More than 3 times per week 311925 135 0.82 (0.69-0.98) 311928 896 0.73 (0.68-0.78) 311929 518 1.06 (0.98-1.16) 311930 1700 1.10 (1.05-1.16) 
Pheterogeneity   <.001   <.001   <.05   <.001 
             
65-69.9             
Rarely/never 141815  98 1.00 (0.81-1.23) 141840 619 1.00 (0.92-1.09) 14817 177 1.00 (0.86-1.17) 141820 485 1.00 (0.91-1.10) 
At most once per week 155983 51 0.58 (0.44-0.76) 156001 488 0.83 (0.76-0.90) 155987 156 0.91 (0.78-1.07) 155988 501 0.99 (0.91-1.08) 
2-3 times week 163739 52 0.57 (0.43-0.74) 163759 462 0.70 (0.64-0.77) 163742 137 0.75 (0.63-0.89) 163743 539 0.99 (0.91-1.08) 
More than 3 times per week 220148 73 0.57 (0.45-0.71) 220186 748 0.76 (0.70-0.81) 220154 253 1.00 (0.88-1.14) 220158 735 1.01 (0.94-1.09) 
Pheterogeneity   <.001   <.001   <.05   .99 
             
70+             
Rarely/never 73044 103 1.00 (0.81-1.23) 73084 913 1.00 (0.93-1.07) 73044 142 1.00 (0.84-1.19) 73052 306 1.00 (0.89-1.12) 
At most once per week 74299 52 0.55 (0.42-0.72) 74326 614 0.74 (0.68-0.80) 74300 120 0.93 (0.77-1.11) 74310 276 0.93 (0.82-1.04) 
2-3 times week 86178 63 0.56 (0.43-0.71) 86191 724 0.69 (0.64-0.75) 86181 102 0.67 (0.55-0.81) 86180 341 0.95 (0.86-1.06) 
More than 3 times per week 118840 110 0.69 (0.57-0.84) 118889 1170 0.75 (0.71-0.80) 118832 190 0.88 (0.76-1.02) 118848 493 1.00 (0.91-1.09) 
Pheterogeneity   <.001   <.001   <.05   .74 
gsCI indicates group-specific confidence interval for RR; and RR indicates relative risk. 
a Adjusted for study region, age, socio-economic status, smoking, alcohol consumption,  height, heart disease/thrombosis, diabetes mellitus, thyroid disease, 





























heart disease/thrombosis, diabetes mellitus, thyroid disease, rheumatoid arthritis/osteoarthritis, BMI and strenuous activity. 
 
 
Supporting Table 12.  Sensitivity analyses of adjusteda relative risks forearm (not wrist), wrist and humerus fracture in post-menopausal women 
according to any activity, stratified by age-bands.   
 




















RR (95% gsCI) 
          
50-64.9          
Rarely/never 213461 280 1.00 (0.89-1.13) 213462 1492 1.00 (0.95-1.05) 213465 425 1.00 (0.91-1.10) 
At most once per week 243702 338 1.00 (0.90-1.12) 243703 1717 0.94 (0.90-0.98) 243703 418 0.91 (0.83-1.01) 
2-3 times week 238933 289 0.89 (0.79-0.99) 238936 1725 0.95 (0.91-1.00) 238933 370 0.86 (0.78-0.95) 
More than 3 times per week 311925 430 1.00 (0.91-1.10) 311938 2331 0.99 (0.95-1.03) 311929 553 0.96 (0.88-1.04) 
Pheterogeneity   .33   .22   .19 
          
65-69.9          
Rarely/never 141827 161 1.00 (0.85-1.17) 141841 801 1.00 (0.93-1.07) 141823 317 1.00 (0.89-1.12) 
At most once per week 155984 146 0.84 (0.71-0.99) 156007 851 0.99 (0.92-1.06) 155996 255 0.83 (0.73-0.93) 
2-3 times week 163749 152 0.77 (0.66-0.91) 163764 972 0.98 (0.92-1.05) 163752 250 0.75 (0.66-0.85) 
More than 3 times per week 220156 243 0.88 (0.77-1.00) 220186 1344 0.96 (0.91-1.02) 220168 409 0.88 (0.80-0.97) 
Pheterogeneity   .16   .86   <.05 
          
70+          
Rarely/never 73036 110 1.00 (0.82-1.21) 73060 634 1.00 (0.92-1.08) 73052 301 1.00 (0.89-1.13) 
At most once per week 74298 102 0.95 (0.78-1.15) 74318 535 0.84 (0.77-0.92) 74315 269 0.99 (0.88-1.12) 
2-3 times week 86184 130 0.97 (0.82-1.15) 86201 710 0.88 (0.82-0.95) 86190 301 0.92 (0.82-1.03) 
More than 3 times per week 118831 183 0.95 (0.82-1.10) 118865 1094 0.95 (0.89-1.00) 118853 454 0.96 (0.87-1.05) 
Pheterogeneity   .23   <.05   .73 
